Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer

被引:58
作者
Zhou, Yujuan
Liao, Qianjin
Han, Yaqian
Chen, Jie
Liu, Zhigang
Ling, Hang
Zhang, Jing
Yang, Wenjuan
Oyang, Linda
Xia, Longzheng
Wang, Li
Wang, Heran
Xue, Lei
Wang, Hui [1 ,2 ]
Hu, Bingqiang [1 ,2 ]
机构
[1] Cent South Univ, Hunan Canc Hosp, Key Lab Translat Radiat Oncol, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China
来源
JOURNAL OF CANCER | 2016年 / 7卷 / 14期
基金
中国国家自然科学基金;
关键词
non-small cell lung cancer; Rac1; epithelial-mesenchymal transition; prognosis; markers; radiotherapy; POTENTIAL THERAPEUTIC TARGET; RADIORESISTANT HEAD; GAMMA-IRRADIATION; INHIBITION; EXPRESSION; INVASION; REARRANGEMENTS; METASTASIS; STATISTICS; CARCINOMA;
D O I
10.7150/jca.16198
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Ras-related C3 botulinum toxin substrate1(Rac1) and epithelial mesenchymal transition (EMT) are key therapeutic targets in cancer. We investigated the clinical significance of Rac1 and markers of EMT expression in non-small cell lung cancer (NSCLC), and their possible correlation with EMT phenotype. Methods: Immunohistochemistry was used to assess the expression of Rac1, Snail1, Twist1, N-cadherin (N-cad), Vimentin (Vim), and E-cadherin (E-cad) in 153 NSCLC paraffin-embedded specimens and 45 normal specimens adjacent to tumors. The correlation of Rac1 and EMT markers with clinicopathological characteristics and the relationship between the protein levels and progression-free survival (PFS) and overall survival (OS) were analyzed. Results: Compared with non-tumor tissues, the NSCLC tissues showed marked elevation in the levels of Rac1, Snail1, Twist1, N-cad, and Vim levels, whereas the E-cad levels were significantly decreased (P < 0.05). The aberrant expression of Rac1 and EMT markers was significantly associated with TNM stage and metastasis (P < 0.05). Increased expression of Rac1 may be associated with poor OS and PFS compared with low expression (P<0.001 and P=0.004). Significant correlations were observed between the EMT markers expressed and OS or PFS(P<0.01). In addition, multivariate analysis indicated that the expression of Rac1, Snail1, Twist1, N-cad, Vim, and E-cad was an independent prognostic factor in NSCLC. Interestingly, Rac1 expression was positively correlated with Snail1, Twist1, N-cad, and Vim levels (r=0.563, r=0.440, r=0.247 r=0.536, P<0.01, respectively) and negatively correlated with E-cad levels (r=-0.464, P<0.001) in NSCLC tissues. Rac1, Twist, Snail1, Vim and N-cad were highly expressed in lung cancer patients resistant to radiotherapy, while E-cad was poorly expressed. Conclusion: Rac1 may promote NSCLC progression and metastasis via EMT, which may be considered as a potential therapeutic target.
引用
收藏
页码:2100 / 2109
页数:10
相关论文
共 50 条
[31]   Expression of Cripto-1 predicts poor prognosis in stage I non-small cell lung cancer [J].
Xu, Chunhua ;
Yuan, Qi ;
Hu, Huidi ;
Wang, Wei ;
Zhang, Qian ;
Li, Li ;
Wang, Jiwang ;
Yang, Rusong .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (17) :9705-9711
[32]   Silencing of RAD51AP1 suppresses epithelial-mesenchymal transition and metastasis in non-small cell lung cancer [J].
Wu, Yuanyuan ;
Wang, Huifeng ;
Qiao, Lijiao ;
Jin, Xiangming ;
Dong, Hui ;
Wang, Yan .
THORACIC CANCER, 2019, 10 (09) :1748-1763
[33]   MicroRNA-187 modulates epithelial-mesenchymal transition by targeting PTRF in non-small cell lung cancer [J].
Cai, Yanjun ;
Ruan, Jian ;
Yao, Xueqing ;
Zhao, Liang ;
Wang, Baocheng .
ONCOLOGY REPORTS, 2017, 37 (05) :2787-2794
[34]   Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition [J].
Liyun Miao ;
Suhua Zhu ;
Yongsheng Wang ;
Yan Li ;
Jingjing Ding ;
Jinghong Dai ;
Hourong Cai ;
Deping Zhang ;
Yong Song .
Medical Oncology, 2013, 30
[35]   Overexpression of LAPTM4B is correlated with tumor angiogenesis and poor prognosis in non-small cell lung cancer [J].
Tang, Han ;
Tian, Hui ;
Yue, Weiming ;
Li, Lin ;
Li, Shuhai ;
Gao, Cun ;
Si, Libo ;
Qi, Lei ;
Lu, Ming .
MEDICAL ONCOLOGY, 2014, 31 (06)
[36]   TRIM22 confers poor prognosis and promotes epithelial-mesenchymal transition through regulation of AKT/GSK3β/β-catenin signaling in non-small cell lung cancer [J].
Liu, Li ;
Zhou, Xiao-Ming ;
Yang, Fang-Fei ;
Miao, Yuan ;
Yin, Yan ;
Hu, Xue-Jun ;
Hou, Gang ;
Wang, Qiu-Yue ;
Kang, Jian .
ONCOTARGET, 2017, 8 (37) :62069-62080
[37]   Overexpression of RCN1 correlates with poor prognosis and progression in non-small cell lung cancer [J].
Chen, Xinming ;
Shao, Weiwei ;
Huang, Hua ;
Feng, Xiaochun ;
Yao, Sumei ;
Ke, Honggang .
HUMAN PATHOLOGY, 2019, 83 :140-148
[38]   Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor Prognosis [J].
Wang, Kaiyuan ;
Zheng, Yu ;
Yang, Yinli ;
Wang, Jian ;
Li, Baihui ;
Wei, Feng ;
Zhao, Hongwei ;
Ren, Xiubao .
FRONTIERS IN ONCOLOGY, 2019, 9
[39]   AP-4 predicts poor prognosis in non-small cell lung cancer [J].
Gong, Hai ;
Han, Shaorong ;
Yao, Hui ;
Zhao, Hui ;
Wang, Yanming .
MOLECULAR MEDICINE REPORTS, 2014, 10 (01) :336-340
[40]   Expression of PD-L1, cancer stem cell and epithelial-mesenchymal transition phenotype in non-small cell lung cancer [J].
Koh, Young Wha ;
Han, Jae-Ho ;
Haam, Seokjin .
PATHOLOGY, 2021, 53 (02) :239-246